The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Feliza Mirasol is the science editor for 

Articles

The start of production of US engineering batches of NXC-201, a CAR-T cell therapy candidate in early clinical development, is the first step in transferring Nexcella’s existing manufacturing process to the United States.

Nexcella Begins Production of CAR-T Cell Therapy Engineering Batches at US Manufacturing Site

API supplier Olon has started construction of a new manufacturing facility in Milan, Italy, which will be dedicated to production of cytotoxic payloads and linkers for ADCs.

Olon Makes Headway into ADCs Market with New Manufacturing Facility in Italy

Webcasts

Webinar Date/Time: Wed, Jun 21, 2023 2:00 PM EDT

Advanced Methodology of Poly(lactic-co-glycolic acid)-based Parenteral Formulations

Webinar Date/Time: Thursday June 29, 2023 at 2pm EDT | 1pm CDT | 11am PDT

Analytics: Manufacturing Scale Label Free Single Cell Analysis

Webinar Date/Time: Thu, Jun 15, 2023 11:00 AM EDT

Stability of Dry Powder Inhaler Protein Formulations

Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the patent industry, and more.

Investigating the Pharmaceutical Ingredients Industry with Myrna Wilson (DCAT Week 2023)

This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.

Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm 

Andrea Lodetti, CEO of Bormioli Pharma, an Italian pharma primary packaging manufacturer, speaks about his company's approach to the US market, supply chain instabilities, sustainability, and more.

Unpacking the Pharma Packaging Market with Andrea Lodetti (DCAT Week 2023)

The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.

TriLink BioTechnologies to Expand Manufacturing Capabilities 

The facility is based on a state-of-the-art design concept that allows maximum flexibility for a multi-product, multi-platform offering.